The molecularisation of security: medical countermeasures, stockpiling and the governance of biological threats

Introduction: The molecular vision of life, medical countermeasures and (in)security -- Contingency, insecurity and the visualisation of life at the molecular level -- Preparedness and governmental support for medical countermeasure development -- Constant biological dynamics, immunology and magic bullets -- Process biology and medical countermeasures to combat viral and bacterial threats -- Conclusion: Rendering the future disease threat constant, manipulable and governable.

Cover -- Half Title -- Series Information -- Title Page -- Copyright Page -- Table of Contents -- Acknowledgements -- Abbreviations -- 1 Introduction: The Molecular Vision of Life, Medical Countermeasures and (In)security -- Medical Countermeasures: a Novel Security Technology -- The Molecular Vision of Life -- Molecular Technologies and Techniques - Visualisation and Manipulation -- Medical Countermeasure Development and Government Support -- The Molecularisation of Security -- The Structure of this Book -- Note -- 2 Contingency, Insecurity and the Visualisation of Life at the Molecular Level -- Security, Circulation and Contingency -- Contingent Molecular Life, Insecurity and Political Uncertainty -- Biopolitical Security Studies and Contingent Molecular Life -- DNA and the Structure of Molecular Life -- Contingent Bacterial Evolution and X-Rays -- X-ray Technology and the Structure of Molecular Life -- Antibiotics: Our Greatest Medical Treasure -- The Emergence of Antibiotic Resistance -- Ribosomes and Tetracycline Resistance -- Contingent Viral Evolution and Gene Mapping -- Mapping Viral Evolution -- Visualising and Mapping Adamantine Resistance -- Conclusion -- Notes -- 3 Preparedness and Governmental Support for Medical Countermeasure Development -- Preparedness and the Value of Medical Countermeasures -- The Swine Flu Fiasco: From Prevention to Preparedness -- The Dual-Purpose Argument -- The Smallpox Vaccination Programme -- BARDA and the Shift to Flexible Biodefence -- BARDA's Broad-Spectrum Therapeutics -- Beyond Vaccines - Antitoxins -- Beyond Vaccines - Antivirals -- Project BioShield, BARDA and Support for Private Industry -- Project BioShield and Support for Private Industry -- Project BioShield and the VaxGen Failure -- BARDA's Advanced Development Support -- BARDA's Financial Support -- BARDA's Technical Support.